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Abstract
Background: Acute febrile illness (AFI) represent a significant health challenge in the Peruvian Amazon basin population
due to their diverse etiologies and the unavailability of specific on-site diagnostic methods, resulting in underreporting of
cases. In Peru, one of the most endemic regions to dengue and leptospirosis is Madre de Dios, a region also endemic to
emergent bacterial etiologic agents of AFI, such as bartonellosis and rickettsiosis, whose prevalence is usually underreported.
We aimed to molecularly identify the presence of Leptospira spp., Bartonella bacilliformis, and Rickettsia spp. by Polymerase
Chain Reaction in serum samples from patients with AFI from Puerto Maldonado-Madre de Dios in Peru.
Methods: Serum samples from patients with acute febrile illness were analyzed by real-time PCR for detecting the presence
of Bartonella bacilliformis, Leptospira spp. and Rickettsia spp.
Results: Bartonella bacilliformis was the most prevalent bacteria identified in 21.6% (30/139) of the samples, followed by
Leptospira spp. in 11.5% (16/139) and Rickettsia spp. in 6.5% (9/139) of the samples. No co-infections were observed between
these bacteria. The most frequent symptoms associated with fever among all groups, were headaches, myalgias, and
arthralgias. We found no statistically significant differences in the clinical presentation between patients infected with
each bacterium.
Conclusions: In a previous study, we shown the presence of dengue, chikungunya, Zika and oropouche virus. We
were able to identify these pathogens in 29.5% of all the samples, with chikungunya and OROV as the most frequently
found in 9.4 and 8.6% of all the samples, respectively. In this study we show that B. bacilliformis (21.6%), Leptospira spp.
(11.5%) and Rickettsia spp. (6.5%) accounted for the main etiologies of AFI in samples from Puerto Maldonado-Madre
de Dios, Perú. Our analysis of their clinical presentation, further shows the importance of implementing more sensitive
and specific on-site diagnostic tools in the national surveillance programs.This study confirms that the un-specificity of
signs and symptoms is not only associated with arboviral infections, but also with the clinical presentation of endemic
bacterial infections.
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Introduction
Acute febrile illness (AFI) is one of the most common
syndromes in the tropics and subtropics associated with
different viral, parasites and bacterial etiologies [1, 2].
The clinical presentation of these infections shares many
symptoms and are, therefore, non-specific to the etio-
logic agent [3]. This poses a diagnostic challenge among
on-site rural clinicians that lack specific diagnostic tools
which in turn has led to under-reporting of these etio-
logical agents in low to middle-income countries in
South America [1, 4, 5].
In recent years, Peru has experienced a resurgence of
arthropod-borne arboviral diseases such as dengue, chi-
kungunya, Zika, and oropouche, as well as leptospirosis
and rickettsiosis [6–10]. Previous reports have shown
that dengue and leptospirosis are the most common
causes of AFI in Peru [5]. However, in the Peruvian
Amazon basin, dengue virus has been reported to ac-
count for the etiology of 6-26% of patients with AFI and
other co-circulating pathogens are hypothesized to have
higher prevalence but have low laboratory confirmation
rates [4, 5]. There is evidence of the presence of Orientia
spp., the etiological agent of scrub typhus, as a probable
cause of AFI in the Peruvian Amazon. Although this has
not been confirmed by molecular methods, the sero-
logical evidence and the multiple possible vectors sug-
gest the presence of this pathogen in tropical areas of
Peru [11].
Madre de Dios is located in the southern region of
Peru, within the Amazon Basin. It is the third most en-
demic region to dengue fever; as well as for other circu-
lating arboviruses including chikungunya and oropouche
virus [6, 7]. Furthermore, the introduction of novel zika
virus infections in this region was described in 2017,
according to national epidemiologic reports [12–16].
Madre de Dios is also the most endemic region in Peru
for leptospirosis, with a total of 1001 cases reported dur-
ing 2016 [17]. Rickettsial diseases are also neglected
infections and a potential cause of AFI that remains
under-reported due to the empirical protocol treatment
and limited access to diagnostic tools in isolated local-
ities within the Peruvian Amazon Basin [10, 18].
Bartonella bacilliformis is the etiological agent of
Carrion's disease, another common, widespread cause of
acute febrile illness endemic to at least 14 territories of
Peru, including Madre de Dios [19]. The endemicity of
this infection is mostly restricted to areas of the Andean
valleys in Peru, however, following the initial identifica-
tion of Carrion’s disease in Madre de Dios during 2014,
a pattern of increasing yearly prevalence has been
observed and this etiology has become an important
cause of AFI [20–23]. Moreover, co-infections between
B. bacilliformis and Leptospira spp. have demonstrated
an increase in the clinical severity of the disease [24].
In a previous study [25], we aimed to molecularly
detect the presence of dengue, chikungunya, Zika and
oropouche virus among patients with AFI in Madre de
Dios. We were able to identify these pathogens in 29.5%
of all the samples, with chikungunya and OROV as the
most frequently found in 9.4% and 8.6% of all the
samples, respectively. We hypothesized that this low
detection rate was due to the implication of other etio-
logical agents responsible for AFI among these patients.
As a branch of our previous research, this study aims to
molecularly identify endemic bacterial etiologies of AFI
including Leptospira spp, Rickettsia spp, and Bartonella
bacilliformis in the serum samples of patients from our
previous study in Madre de Dios and to describe their
clinical and epidemiological characteristics.
Materials and methods
Place of study
This is a consecutive cross-sectional study that was
conducted in Puerto Maldonado between January and
March of 2016 within nine primary health care centers
in coordination with the “Regional Directive of Health
in Madre de Dios.” Puerto Maldonado is the capital of
Madre de Dios, located in the Amazon rainforest at
308 meters above sea level. Patients that fulfilled the in-
clusion criteria were recruited for the molecular detec-
tion of Bartonella bacilliformis, Leptospira spp. and
Rickettsia spp.
Study subjects
The inclusion criteria were patients who presented to In-
ternal Medicine-Pediatrics outpatient health centers with
acute febrile illness, defined as an axillary temperature
greater than or equal to 38°C within at least 7 days prior
to consultation without an identifiable source of infection.
The following signs and symptoms were assessed and
recorded by the attending physician in a standardized
questionnaire: headache, muscle pain, joint pain, loss of
appetite, retro-ocular pain, nausea, vomiting, chills, dizzi-
ness, rash, sore throat, photophobia, abdominal pain,
cough, pallor, diarrhea, conjunctival injection, rhinorrhea,
shortness of breath, dysuria, fatigue, jaundice and seizures.
Exclusion criteria were patients who had received
treatment before the consult, patients with an incom-
plete record of their medical information and patients
with an identifiable source of infection, such upper or
lower respiratory tract infections, urinary tract infec-
tions, among others.
Ethics statement
This study has been approved by two independent Ethics
Committees from Universidad Peruana de Ciencias
Aplicadas and Hospital Regional de Cajamarca. A writ-
ten informed consent was signed before enrollment; for
Ricapa-Antay et al. BMC Infectious Diseases          (2018) 18:618 Page 2 of 8
participants under 18 years old the informed consent was
signed by their respective guardians before enrollment.
Samples
A total of 139 patients were sampled and blood was col-
lected by using Vacuette® TUBE Serum Separator Clot
Activator (Vacuette, Greiner Bio-One, Kremsmünster,
Austria). After collection, all the samples were stored at
-80°C and transported to Lima (Peru) under standard-
ized frozen conditions to perform molecular assays. In a
previous study [25], in these samples we detect the pres-
ence of dengue, chikungunya, Zika and oropouche.
DNA extraction
DNA extraction was performed following the instructions
of a commercial extraction kit (High Pure Kit Preparation
template, Roche Applied Science, Mannheim, Germany)
using 200 μl of the collected samples. Bacterial DNA
obtained after extraction was eluted in 100 μl of nuclease-
free water and then processed or stored at -20°C until use.
PCR amplification
Real-time PCR assay detection of Bartonella bacilliformis,
Leptospira spp. and Rickettsia spp.
The PCR was performed using specific primers and
probe for species-specific gene of Bartonella bacillifor-
mis [26], gene PanR8 of Rickettsia spp. [27] and gene
LipL32 of Leptospira spp. [28] as previously described.
Each reaction contained 5 μl of template DNA and 15 μl
of PCR master mix (FastStar PCR Master, Roche Diag-
nostic, Germany) including 1 μl (10 μM) each of forward
and reverse primers and 1.2 μl (10 μM) Taqman probe.
The qPCR conditions were 95°C for 2 minutes, 55 cycles
of 3 seconds at 95°C, 30 seconds at 55°C and 10 seconds
at 72°C.
For B. bacilliformis, the collection strain (CIP 57.19,
NCTC 12135) was used as the positive control, and the
positive control for Leptospira spp. and Rickettsia spp.
were used strains of Leptospira noguchii and Rickettsia
typhi provided by the microbiology laboratory of Insti-
tute of Nutritional Research in Lima, Peru. A PCR reac-
tion without template DNA was used as the negative
control in all the cases. As an internal control, a PCR
targeting the gene encoding human beta-globin was
included in each PCR series to rule out the possibility of
PCR inhibition caused by inhibitory molecules still
present in the sample after extraction and purification of
the DNA.
Data analysis
Qualitative variables were reported as frequencies and
percentages. All analyses were processed with the IBM
Statistical Package for the Social Sciences (SPSS) software
version 21.0 (SPSS, Chicago, IL, USA). The confidence
interval to the 95% was estimated for each frequency or
odds, and two frequencies or odds were compared with
the odds ratio. Chi-square test (|2) was used to estimate
differences statistical (p δ 0.05). Pearson correlation was
used to determined statistical association.
Results
Demographic characteristics
A total of 139 samples from patients with acute febrile
illness (AFI) from Puerto Maldonado-Madre de Dios
were included and molecularly analyzed in this study.
Figure 1 shows the etiological detection distribution and
demonstrates the significantly higher frequency of Barto-
nella bacilliformis (21.6%, p<0.05) and Leptospira spp.
(11.5%, p<0.05) as etiologic agents of AFI with odds of
0.275 (CI95%: 0.184-0.411) and 0.130 (CI95%: 0.077-
0.218), respectively. Additionally, Rickettsia spp. was the
less frequent bacterial etiologic agent identified in 6.5%
(p>0.05) of all cases with odds of 0.069 (CI95%: 0.032-
0.134). Thus, these three bacterial etiological agents to-
gether were responsible for 40% of the cases of AFI in
the population studied.
Table 1 shows AFI frequencies distributed by ages,
with most patients positive to at least one of the etio-
logic agents being between 20 to 44 years old. However,
the exhaustive analysis of frequency distributions by age
and etiological agents (Fig. 2) shows that all distributions
by ages correspond to Gaussian models. Patients
infected with Bartonella bacilliformis showed a wide
symmetric distribution centered in the range of 20-44
years, similar to the total population with AFI. However,
the patients infected with Leptospira spp. and Rickettsia
spp. showed significantly different characteristics in their
distributions (|2, p<0.05) in comparison to the total
population with AFI. The distribution was wide and cen-
tered between the ranges of 20-44 and 45-59 years old,
indicating that adults were the most affected when
infected with Leptospira spp. Meanwhile, when Rickett-
sia spp. was responsible for AFI, the distribution was
narrower and centered in the group of young people, be-
tween 5-19 and 20-44 years old (Fig. 2). Finally, the
distribution of AFI bacterial etiology by sex did not show
any significant differences. Only a slight tendency of a
greater distribution of Leptospira in males can be ob-
served with a frequency of 62.5% (CI95%: 38.6-81.5)
(Table 1).
Clinical presentation
In this study, the most frequent symptom among all
positive patients was a headache in 79.9% of all cases,
followed by myalgias and arthralgias with 69% and 64%,
respectively. The clinical presentation in patients posi-
tive for Bartonella bacilliformis, Leptospira spp. and
Rickettsia spp., was similar. In patients infected with B.
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bacilliformis, headaches were present in 73.3%, followed
by myalgias and arthralgias in 60% of samples. Similarly,
patients positive for Leptospira spp, had headaches
(87.5%), myalgias (68.8%) and arthralgias (62.5%) as their
most common symptoms (Table 2).
Discussion
Acute febrile illness (AFI) is a common infectious syn-
drome in the Peruvian Amazon basin, caused by vari-
ous bacterial and viral pathogens. In recent years,
cyclic weather phenomena such as El Niño-Southern
Oscillation have been implicated in the increasing
incidence and resurgence of some neglected infections
responsible for AFI in Peru [6–8, 19, 26]. However,
due to the lack of sensitive and specific on-site diag-
nostic methods, most of these pathogens remain
poorly characterized during outbreaks, leading to an
underestimation of the real disease burden [27].
During this study, we were able to collect and analyze
the clinical presentation of patients with AFI caused by
three different bacterial etiologies. As shown in Fig. 3a,
the frequency of symptoms of patients infected with
Bartonella bacilliformis, Leptospira spp. and Rickettsia
spp., were ordered in a descending frequency and com-
pared with the signs and symptoms of all patients with
AFI that includes those positive to arboviruses from our
previous study. The analysis of the matrices shows that
the frequency distributions were statistically different
(χ2, p<0.05). In the case of patients with AFI caused by
Bartonella bacilliformis and Leptospira spp, a bimodal
distribution of symptoms was observed in comparison to
the unimodal matrix of total number patients with AFI;
whereas the matrix of the AFI caused by Rickettsia spp.
shows a unimodal array characterized by very low
frequencies (Fig. 3a).
However, the correlation observed between the
frequencies of the signs and symptoms for the total
number of patients with AFI and those infected with
Bartonella bacilliformis and Leptospira spp. were very
positive. Their association was 98.7% and 99.1% respect-
ively; and in the case of AFI caused by Rickettsia spp. e,
it was positive but with a low correlation of 82.2% (Fig.
3b). These results highlight the great challenge clinicians
face when making an etiological diagnosis without
specific diagnostic tools among patients living in regions
endemic to both bacterial and viral etiologies of AFI.
Madre de Dios is endemic to dengue virus, oropouche
virus, malaria and leptospirosis [6, 7, 10–13, 17]. Other
bacterial pathogens such as Rickettsia spp. and B. bacilli-
formis have been implicated as etiological causes of AFI;
however, few reports describe the burden these entities
account for in this region [10, 19, 20]. Recently a
meta-analysis [29] describes in Colombia the presence of
Leptospira and Rickettsia, with frequencies in the ranges
of 14-27% and 2-6% respectively. In our previous study,
we identified the presence of arboviruses including
dengue, chikungunya, Zika, and oropouche, in 139 pa-
tients with AFI from Puerto Maldonado in Madre de
Fig. 1 Frequency of Bartonella bacilliformis, Leptospira spp. and Rickettsia
spp. as etiological agents of AFI in Puerto Maldonado, Madre de
Dios, Peru
Table 1 Demographics in patients with Bartonella bacilliformis, Leptospira spp. and Rickettsia spp. from Puerto Maldonado- Madre de
Dios, Peru
AFI Total Bartonella bacilliformis Leptospira spp. Rickettsia spp.
N = 139 (%) N = 30 (%) CI 95% (%) OR N = 16 (%) CI 95% (%) OR N = 9 (%) CI 95% (%) OR
Age (years)
0–4 6 4.3 1 3.3 0.6–16.7 0.764 0 0 0.0–19.4 0.000 0 0 0.0–29.9 0.000
5–19 30 21.6 5 16.7 7.3–33.6 0.727 2 12.5 3.5–36.0 0.519 2 22.2 6.3–54.7 1.038
20–44 81 58.3 20 66.7 48.8–80.8 1.432 9 56.2 33.2–76.9 0.921 7 77.8 45.3–93.7 2.506
45–59 16 11.5 2 6.7 1.9–21.3 0.549 5 31.2 14.2–55.6 3.494 0 0 0.0–29.9 0.000
≥ 60 6 4.3 2 6.7 1.9–21.3 1.583 0 0 0.0–19.4 0.000 0 0 0.0–29.9 0.000
Gender
Female 63 45.3 14 46.7 30.2–63.9 1.056 6 37.5 18.5–61.4 0.724 5 55.6 26.7–81.1 1.508
Male 76 54.7 16 53.3 36.1–69.8 0.947 10 62.5 38.6–81.5 2.011 4 44.4 18.9–73.3 0.663
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Dios [25, 29]. We were able to identify at least one of
these viruses in 29.5% (41/139) of cases. In the present
study, we have analyzed the same samples to identify
Bartonella bacilliformis, Leptospira spp. and Rickettsia
spp molecularly. Interestingly, we were not able to
detect co-infections between the identified viruses
from our previous study and the bacterial pathogens
identified in this study. Furthermore, we were able to
identify B. bacilliformis in 21.6% (30/139) of samples,
Leptospira spp. in 11.5% (16/139) and Rickettsia spp.
in 6.5% (9/139) cases, without any co-infections
between these bacteria.
Bartonella bacilliformis is endemic to many regions in
Peru and its neighboring countries [30]. The on-site
diagnosis of this infection is mainly based on the clinical
suspicion and extensive use of peripheral blood smears
given the intraerythrocytic nature of the bacteria. How-
ever, the sensitivity of this method has been reported to
be low, between 24%-36% [31, 32], in comparison to mo-
lecular methods with reported sensitivity and specificity
of 100% [33]. In contrast to the national reports that
found 2 positive cases in 2016 in Madre de Dios [34], we
Table 2 Clinical symptoms in patients with positive diagnostic for Bartonella bacilliformis, Leptospira spp. and Rickettsia spp. from
Puerto Maldonado-Madre de Dios, Peru
Signs and symptoms AFI Total Bartonella bacilliformis Leptospira spp. Rickettsia spp.
N = 139 % N = 30 % CI 95% (%) OR N = 16 % CI 95% (%) OR N = 9 % CI 95% (%) OR
Headaches 111 79.9 22 73.3 55.6–85.8 0.694 14 87.5 64.0–96.5 1.766 3 33.3 12.1–64.6 0.126
Myalgia 96 69.1 18 60.0 42.3–75.4 0.672 11 68.8 44.4–85.8 0.985 2 22.2 6.3–54.7 0.128
Arthralgia 89 64.0 18 60.0 42.3–75.4 0.843 10 62.5 38.6–81.5 0.936 1 11.1 2.0–43.5 0.070
Loss of appetite 48 34.5 7 23.3 11.8–40.9 0.577 5 31.2 14.2–55.6 0.862 0 0 0.0–29.9 0.000
Retroocular pain 48 34.5 9 30.0 16.7–47.9 0.812 6 37.5 18.5–61.4 1.138 0 0.0 0.0–29.9 0.000
Nausea 40 28.8 10 33.3 19.2–51.2 1.238 4 25.0 10.2–49.5 0.825 0 0.0 0.0–29.9 0.000
Chills 22 15.8 7 23.3 11.8–40.9 1.619 2 12.5 3.5–36.0 0.760 0 0.0 0.0–29.9 0.000
Vomits 11 7.9 2 6.7 1.9–21.3 0.831 2 12.5 3.5–36.0 1.662 0 0.0 0.0–29.9 0.000
Dizziness 10 7.2 2 6.7 1.9–21.3 0.921 1 6.2 1.1–28.3 0.860 0 0.0 0.0–29.9 0.000
Rash 10 7.2 2 6.7 1.9–21.3 0.921 1 6.2 1.1–28.3 0.860 0 0.0 0.0–29.9 0.000
Sorethroat 9 6.5 3 10.0 3.5–25.6 1.605 2 12.5 3.5–36.0 2.064 0 0.0 0.0–29.9 0.000
Photophobia 9 6.5 3 10.0 3.5–25.6 1.605 1 6.2 1.1–28.3 0.963 0 0.0 0.0–29.9 0.000
Abdominal pain 8 5.8 1 3.3 0.6–16.7 0.565 2 12.5 3.5–36.0 2.340 1 11.1 2.0–43.5 2.047
Cough 6 4.3 2 6.7 1.9–21.3 1.583 1 6.2 1.1–28.3 1.478 0 0.0 0.0–29.9 0.000
Pallor 5 3.6 2 6.7 1.9–21.3 1.914 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Diarrhea 5 3.6 2 6.7 1.9–21.3 1.914 1 6.2 1.1–28.3 1.787 0 0.0 0.0–29.9 0.000
Conjunctival injection 5 3.6 2 6.7 1.9–21.3 1.914 1 6.2 1.1–28.3 1.787 0 0.0 0.0–29.9 0.000
Rhinorrhea 4 2.9 1 3.3 0.6–16.7 1.164 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Shortness of breath 3 2.2 0 0.0 0.0–11.4 0.000 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Dysuria 2 1.4 1 3.3 0.6–16.7 2.362 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Fatigue 2 1.4 0 0.0 0.0–11.4 0.000 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Jaundice 2 1.4 1 3.3 0.6–16.7 2.362 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Seizures 1 0.7 1 3.3 0.6–16.7 4.759 0 0.0 0.0–19.4 0.000 0 0.0 0.0–29.9 0.000
Fig. 2 Distribution of AFI frequency with and without diagnosis of the
etiological agent in the population of Puerto Maldonado-Madre de Dios,
Peru. Ordered by age ranges, the curves are the Gauss models fitted
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molecular identified Bartonella bacillliformis in 30 pa-
tients (21.6%) with acute febrile illness during our study
3-month study period. This contrasting frequency may
be due to the molecular method employed and high-
lights the importance of implementing these tools to en-
hance national surveillance programs.
Leptospirosis is a widespread, underreported and, preva-
lent zoonotic disease with no reliable global incidence
data. A model made by the World Health Organization’s
(WHO) about the burden of the disease estimated that
there were 873 000 cases worldwide annually with 48 600
deaths [35]. In Peru, the incidence of leptospirosis is
approximately 2 000 cases annually. In 2016, 2 063 cases
of leptospirosis were reported, and nearly 50% (n=1002)
corresponded to patients from Madre de Dios [36].
In the present study, we were able to identify 16
(11,5%) cases of Leptospira spp. infection from 139
samples of patients with AFI. The clinical course of
leptospirosis is variable and most cases are self-limited
or subclinical, while less frequent cases are severe and
potentially fatal [37]. The most common symptoms
found in this group were headaches (87,5%), myalgias
(68,8%), and arthralgias (62,5%) that corresponds the
clinical presentation of mild leptospirosis. This presen-
tation may be to the fact that all the studied samples
came from outpatient health care centers. Furthermore,
a case-control study found that risk factors for the de-
velopment of severe leptospirosis included a delay of
more than 2 days following the start of symptoms in
the initiation of antibiotic therapy [38], highlighting the
importance of accurate and timely diagnosis of this
emergent bacterial disease.
In our study, we were able to detect 9 cases (6.5%) of
Rickettsia spp. via real-time PCR. This is a fairly high
frequency considering that Rickettsia spp. is an intracel-
lular organism and some studies report a low sensitivity
using molecular methods [39]. It is important to con-
sider the results of some serological studies that suggest
a high level of transmission of spotted fever group rick-
ettsiae (SFGR) and of the Tifus group rickettsiae (TGR)
in the Peruvian Amazon, 46.3% and 10.3% respectively.
More studies identifying Rickettsia species are needed to
assess their role in the AFI and quantify the impact of
the associated disease burden [40, 41]. Our findings also
show that the clinical presentation of this infection is
non-specific when compared to patients with AFI, fol-
lowing a pattern reported in previous studies [42, 43].
Surprisingly, no co-infections were identified in patients
infected with Rickettsia spp.
The main limitation of this study is our inability estab-
lish causality between the identified bacteria and the
clinical presentation. However, due to the similar symp-
toms registered across all groups, we can still conclude
that molecular diagnostic tests should be mandatory for
the etiological diagnosis of AFI. Finally, as we only stud-
ied cases in the outpatient setting, more severe cases
that required hospitalization might not have been
included in our analysis.
Conclusion
Our study series have shown that arboviruses (29.5%), B.
bacilliformis (21.6%), Leptospira spp. (11.5%) and Rick-
ettsia spp. (6.5%) accounted for the main etiologies of
AFI. Our analysis of their clinical presentation, further
Fig. 3 Analysis of signs and symptoms for the AFI diagnosed with an etiological agent. a Frequencies distribution of the signs and symptoms. b
Scatter matrices for the correlation of signs and symptoms. Pearson coefficient (r) and associated probability (p) to the correlation
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shows the importance of implementing more sensitive
and specific on-site diagnostic tools in the national sur-
veillance programs, as this study confirms that the
un-specificity of signs symptoms is not only associated
with arboviral infections [25], but also with the clinical
presentation of endemic bacterial infections.
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